FindTrial
Sign In

Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping

Diagnosis et Treatment of Asthma in Athlete : Boundary Between Disease and Doping

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02655328
Acronym
SALBEXO
Enrollment
14
Registered
2016-01-14
Start date
2009-03-31
Completion date
2013-07-31
Last updated
2016-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Asthma

Keywords

asthma, athlete

Brief summary

This study will determine the pharmacokinetic profile of the salbutamol concentration in the urine while athletes are resting or during exercise.

Interventions

OTHERblood sample

blood sample

OTHERurine sample

urine sample

Sponsors

University Hospital, Toulouse
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* patient who hold a license in a sport federation, and do at least 8 hours of sport each week * asthmatic patient

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
impact of exercise on pharmacokinetics profile4 daysimpact of exercise on pharmacokinetics profile of salbutamol concentration in urine

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026